Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126785011 | 12678501 | 1 | I | 2016 | 20160405 | 20160823 | 20160823 | PER | US-PRESTIUM-2016RN000191 | RENAISSANCE | 0.00 | F | Y | 0.00000 | 20160823 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126785011 | 12678501 | 1 | PS | LITHIUM CARBONATE. | LITHIUM CARBONATE | 1 | 300 MG, BID | 76243 | 300 | MG | CAPSULE | BID | |||||||
126785011 | 12678501 | 2 | SS | LITHIUM CARBONATE. | LITHIUM CARBONATE | 1 | 300 MG, NIGHTLY | 76243 | 300 | MG | CAPSULE | ||||||||
126785011 | 12678501 | 3 | C | HYQVIA | HUMAN IMMUNOGLOBULIN GHYALURONIDASE RECOMBINANT HUMAN | 1 | 30 G, MONTHLY | 0 | 30 | G |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126785011 | 12678501 | 1 | Product used for unknown indication |
126785011 | 12678501 | 3 | Immune system disorder |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126785011 | 12678501 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |